By linking the PI3K-Akt-mTOR pathway’s promotion of lipid synthesis to the suppression of ferroptosis, Yi (2020) provided a strong rationale for a new therapeutic strategy: inhibiting this pathway to dismantle cancer cells’ defenses and trigger cell death. Here, AKT1 is linked to cancer.